I have covered Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) twice before, and on both occasions, my predictions of share price performance on the basis of fundamental analysis were proved correct over the following months. MyI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the ke ...